Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>

Short Interest in Pharming Group (OTCMKTS:PHGUF) Drops By 46.4%

kopsource ·  {{timeTz}}

Pharming Group (OTCMKTS:PHGUF – Get Rating) was the target of a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 1,279,100 shares, a drop of 46.4% from the June 15th total of 2,387,900 shares. Based on an average daily volume of 1,000 shares, the days-to-cover ratio is currently 1,279.1 days.

Pharming Group Stock Performance

Pharming Group stock remained flat at $0.79 during mid-day trading on Friday. The company has a fifty day simple moving average of $0.80 and a two-hundred day simple moving average of $0.85. Pharming Group has a twelve month low of $0.74 and a twelve month high of $1.18. The company has a current ratio of 5.33, a quick ratio of 4.75 and a debt-to-equity ratio of 0.82.

Get Pharming Group alerts:

Pharming Group Company Profile

(Get Rating)

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema.

Featured Stories

  • Get a free copy of the StockNews.com research report on Pharming Group (PHGUF)
  • MarketBeat: Week in Review 7/11 – 7/15
  • Should You Have These Two Banks In Your Portfolio?
  • Is Coupang's Stock On The Verge Of A Turnaround?
  • Why Shopify Stock Split...And is as Shoppable as Ever
  • Verint Systems Stock is a Customer Engagement Play

Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.

Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.

Back to the Top